Literature DB >> 24398859

RANK-mediated signaling network and cancer metastasis.

Gina Chia-Yi Chu1, Leland W K Chung.   

Abstract

Cancer metastasis is highly inefficient and complex. Common features of metastatic cancer cells have been observed using cancer cell lines and genetically reconstituted mouse and human tumor xenograft models. These include cancer cell interaction with the tumor microenvironment and the ability of cancer cells to sense extracellular stimuli and adapt to adverse growth conditions. This review summarizes the coordinated response of cancer cells to soluble growth factors, such as RANKL, by a unique feed forward mechanism employing coordinated upregulation of RANKL and c-Met with downregulation of androgen receptor. The RANK-mediated signal network was found to drive epithelial to mesenchymal transition in prostate cancer cells, promote osteomimicry and the ability of prostate cancer cells to assume stem cell and neuroendocrine phenotypes, and confer the ability of prostate cancer cells to home to bone. Prostate cancer cells with activated RANK-mediated signal network were observed to recruit and even transform the non-tumorigenic prostate cancer cells to participate in bone and soft tissue colonization. The coordinated regulation of cancer cell invasion and metastasis by the feed forward mechanism involving RANKL, c-Met, transcription factors, and VEGF-neuropilin could offer new therapeutic opportunities to target prostate cancer bone and soft tissue metastases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398859      PMCID: PMC4087108          DOI: 10.1007/s10555-013-9488-7

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  131 in total

1.  Evaluating prostate cancer cell culturing methods: a comparison of cell morphologies and metabolic activity.

Authors:  Jennifer J Winkenwerder; Patricia L Palechek; Julie S Reece; Mark A Saarinen; Mark A Arnold; Michael B Cohen; David W Murhammer
Journal:  Oncol Rep       Date:  2003 Jul-Aug       Impact factor: 3.906

2.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

3.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

4.  Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Daqing Wu; Zhihui Xie; Hiromitsu Mimata; Majd Zayzafoon; Andrew N Young; Fray F Marshall; M Neale Weitzmann; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

5.  Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells.

Authors:  Giovanna Danza; Claudia Di Serio; Fabiana Rosati; Giuseppe Lonetto; Niccolò Sturli; Doreen Kacer; Antonio Pennella; Giuseppina Ventimiglia; Riccardo Barucci; Annamaria Piscazzi; Igor Prudovsky; Matteo Landriscina; Niccolò Marchionni; Francesca Tarantini
Journal:  Mol Cancer Res       Date:  2011-12-15       Impact factor: 5.852

6.  MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Authors:  Takeshi Yamasaki; Naohiko Seki; Hirofumi Yoshino; Toshihiko Itesako; Hideo Hidaka; Yasutoshi Yamada; Shuichi Tatarano; Tomokazu Yonezawa; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  J Urol       Date:  2013-02-27       Impact factor: 7.450

7.  GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche.

Authors:  Yusuke Shiozawa; Elisabeth A Pedersen; Russell S Taichman
Journal:  Exp Hematol       Date:  2009-11-14       Impact factor: 3.084

Review 8.  Bone metastasis: pathogenesis and therapeutic implications.

Authors:  Philippe Clezardin; Anna Teti
Journal:  Clin Exp Metastasis       Date:  2007-11-16       Impact factor: 5.150

9.  Vitamin C intake inhibits serum lipid peroxidation and osteoclast differentiation on alveolar bone in rats fed on a high-cholesterol diet.

Authors:  Toshihiro Sanbe; Takaaki Tomofuji; Daisuke Ekuni; Tetsuji Azuma; Koichiro Irie; Naofumi Tamaki; Tatsuo Yamamoto; Manabu Morita
Journal:  Arch Oral Biol       Date:  2008-12-24       Impact factor: 2.633

10.  Effect of PF-02341066 and radiation on non-small cell lung cancer cells.

Authors:  Vasu Tumati; Subashri Kumar; Lan Yu; Benjamin Chen; Hak Choy; Debabrata Saha
Journal:  Oncol Rep       Date:  2012-12-18       Impact factor: 3.906

View more
  23 in total

Review 1.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

2.  Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.

Authors:  Qinlong Li; Quanlin Li; Jill Nuccio; Chunyan Liu; Peng Duan; Ruoxiang Wang; Lawrence W Jones; Leland W K Chung; Haiyen E Zhau
Journal:  Prostate       Date:  2015-05-19       Impact factor: 4.104

3.  HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.

Authors:  Kathleen C Day; Guadalupe Lorenzatti Hiles; Molly Kozminsky; Scott J Dawsey; Alyssa Paul; Luke J Broses; Rajal Shah; Lakshmi P Kunja; Christopher Hall; Nallasivam Palanisamy; Stephanie Daignault-Newton; Layla El-Sawy; Steven James Wilson; Andrew Chou; Kathleen Woods Ignatoski; Evan Keller; Dafydd Thomas; Sunitha Nagrath; Todd Morgan; Mark L Day
Journal:  Cancer Res       Date:  2016-10-28       Impact factor: 12.701

Review 4.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

5.  Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases.

Authors:  Nolan Priedigkeit; Rebecca J Watters; Peter C Lucas; Ahmed Basudan; Rohit Bhargava; William Horne; Jay K Kolls; Zhou Fang; Margaret Q Rosenzweig; Adam M Brufsky; Kurt R Weiss; Steffi Oesterreich; Adrian V Lee
Journal:  JCI Insight       Date:  2017-09-07

Review 6.  The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of Autism.

Authors:  Kathie L Eagleson; Zhihui Xie; Pat Levitt
Journal:  Biol Psychiatry       Date:  2016-09-15       Impact factor: 13.382

Review 7.  Current and emerging therapies for bone metastatic castration-resistant prostate cancer.

Authors:  Jeremy S Frieling; David Basanta; Conor C Lynch
Journal:  Cancer Control       Date:  2015-01       Impact factor: 3.302

Review 8.  Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience.

Authors:  Miriam Hegemann; Jens Bedke; Arnulf Stenzl; Tilman Todenhöfer
Journal:  Ther Adv Urol       Date:  2017-02-06

Review 9.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

Review 10.  Regulation of prostate cancer progression by the tumor microenvironment.

Authors:  Stephen L Shiao; Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Lett       Date:  2016-01-28       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.